SCHEMBL23641806

SCHEMBL23641806

CCC(C)CC(=O)N(C)C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14671182 0.78 ALDH1A1 (0.41) —
SCHEMBL20960430 0.77 CHRNB2 (0.31) —
SCHEMBL12809682 0.77 GABRP (0.37) —
SCHEMBL21986954 0.74 CA1 (0.33) —
SCHEMBL20803525 0.73 — —
SCHEMBL11892670 0.72 — —
SCHEMBL4913736 0.72 — —
SCHEMBL8399215 0.71 LMNA (0.46) —
SCHEMBL12345501 0.71 FAAH (0.33) —
SCHEMBL24772550 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3848054-A1 NOVEL CYCLIC DINUCLEOTIDE DERIVATIVE AND ANTIBODY-DRUG CONJUGATE THEREOF Daiichi Sankyo Company, Limited (JP) 2021-07-14 — — EP disclosed
Send feedback